Anxiety can manifest in a wide range of ways. Apart from the internal emotional fearfulness, symptoms can include irritability, agitation, muscle tension, palpitations, sweating, insomnia, breathlessness, poor concentration, reduced socialisation and ability to undertake everyday activities. It is the most prevalent mental health disorder affecting children and adults, but many more people are dealing with problematic anxiety symptoms without any diagnosis.
In our increasingly changing world, where our daily exposure to stressful stimuli and life challenges can produce a rising barometer of worries, anxiety is often a major impediment to leading a fulfilling and happy life. Like most other health woes, humans have long pursued various practices to help overcome anxiety, the most popular of which is alcohol. Then there are drug medications, which have long been used to relieve anxiety, and remain widely prescribed.
Barbiturates were the first of these, sedative and anticonvulsant drugs which became popular particularly with sleep-deprived young mothers in the middle of last century, but which lead to the overdose deaths of thousands of people, including Elvis Presley and Marilyn Monroe. The next day ‘hangover effect’ from barbiturates was also always a problem, and development of a new chemical group of anxiolytic (anti-anxiety) and sedative drugs known as the benzodiazepines, lead to these superceding the barbiturates for the treatment of anxiety and insomnia. Benzodiazepines seem to act predominantly through stimulating GABA (gamma amino butyric acid) receptors in the central nervous system, and the commercialisation of Valium® (diazepam) by Roche in 1963 marked the start of a period during which this and other benzodiazepine drugs such as lorazepam, alprazolam and clonazepam began to be widely prescribed by GP’s and psychiatrists for anxiety and sleep difficulties. Between 1969 and 1982 Valium® was the most prescribed drug in the U.S., during which time Roche’s share price soared.
While safer than barbiturates, and effective as a ‘quick fix’ for anxious feelings or insomnia, safety concerns for benzodiazepines soon emerged. Feelings of fatigue, or a hangover the following day when taken as sleeping tablets, and a wide range of other side effects are all too common experiences. Most significant of these is the development of tolerance when they are used for more than a short period of time. As anyone who has been through it will testify, withdrawing from long term benzodiazepine use is a hugely stressful, unpleasant and often very protracted experience.
Feelings of depression can both contribute to or arise from excessive anxiety, and it is not uncommon for feelings of low mood and a low tolerance to stress, to be experienced together with anxiety. Apart from GABA, neurotransmitters such as serotonin, adrenaline and dopamine are intrinsically involved in influencing our emotions and mood, interacting together in complex ways that scientists still have little understanding of. It is therefore not surprising that many SSRI’s (selective serotonin reuptake inhibitor) drugs, used primarily as antidepressants, can have an anxiolytic effect in some people, and in many countries, these are often prescribed instead of or together with benzodiazepines, for anxiety conditions.
While sometimes effective as anxiolytics and less likely to produce adverse effects than most older generation tricyclic antidepressants, some find that SSRI’s can cause or increase anxiety feelings, or experience any one or more of a wide range of unpleasant side effects including insomnia, weight gain, emotional numbing or sexual dysfunction.
Another class of non-benzodiazepine sleeping tablets, the so-called ‘Z-drugs’ such as zopiclone and zolpidem, have become popular in recent years, and while initially thought to be less habit-forming than benzodiazepines, they can also be very difficult to withdraw from after more than short-term use.
A large number of herbs have been traditionally used for nervous conditions and their anxiolytic effects, several of which have been shown in clinical trials to be beneficial as anxiety treatments. These include Chamomile, Skullcap, Passionflower, Valerian, Kava, Lemon balm and Withania. Despite the number of well-designed trials undertaken to date being relatively low, and results sometimes variable depending on the particular herbal product(s) and dosages used, results are encouraging and in all cases show a better safety profile than for comparable anxiolytic drugs.
Of these, Kava (Piper methysticum), is the most studied, and is a non-addictive anxiolytic with great potential to treat anxiety. Its effectiveness in treating anxiety has been affirmed through several clinical trials and meta-analysis(1-3). While case reports of liver toxicity associated with kava usage lead to its restriction in some countries at the end of last century, use of the wrong plant part as raw material, or use in combination with alcohol or various drugs, were likely contributory factors. Also the frequency of such adverse events reports was substantially less than that for paracetamol, a commonly used analgesic.
Aerial parts of the herb Passionflower (Passiflora incarnata), have also been taken for anxiety for many centuries, and in a trial involving 36 outpatients with generalized anxiety disorder, it was as effective as the benzodiazepine drug oxazepam, but unlike oxazepam caused no impairment of job performance(4).
Roots of the herb Withania (Withania somnifera, Ashwagandha), have a subtle but powerful nervous system and adrenal tonic action, which insulates the nervous system from stress, and enables the adrenal glands to be better prepared to respond appropriately to stressful stimuli. A large number of scientific papers now support its applications for stress-associated anxiety conditions, including several recent human clinical trials(5,6).
While further studies involving greater participant numbers and longer term treatment are needed to identify optimal dosages and phytochemical makeup of the treatments involved, the fact that most herbal anxiolytic agents are safe and have the same or only a slightly higher incidence of adverse effects to placebo, is clear. It is therefore logical that before reverting to drug medications, more likely to produce unwanted adverse effects and in some cases long term dependency, herbal anxiolytics should be tried, in anxiety conditions.
Refs:
- Sarris J, Aust NZ J Psychiatry 2011; 45(1):27-35.
- Sarris J, J Clin Psychopharmacol 2013; 33(5):643-648.
- Savage K et al, Trials 2015; 16:493.
- Akhondzadeh S et al, J Clin Pharm Ther 2001; 26(5):363-367.
- Chandrasekhar K et al, Indian J Psychol Med 2012; 34(3):255-262.
- Pratte MA et al, J Altern Complement Med 2014; 20(12):901-908



While not pleasing to all, other flowering plants such as the invasive introduced gorse (Ulex europaeus), presently plays an important role as a food source for bees in some areas. However, we should be planting other native species such as Hoheria (Hoheria populnea), Whauwhaupaku or Five Finger (Pseudopanax arboreus) and many others, to provide pollen and nectar as a replacement for that from this imported thorny plant.

The New Zealand native Manuka (Leptospermum scoparium) is one of these, and the ability of certain forms of Manuka Honey to act as potent healing agents for wounds and ulcers, is becoming increasingly recognised(8). Many clinical trials have now shown manuka honey dressings to have unique healing properties in chronic leg ulcers and other stubborn skin infections, and synergistic antimicrobial activities with various antibiotics, have recently been reported(10,11).
he haze contains particulate matter, fine particulate matter, heavy metals and poly aromatic hydrocarbons, and at its peak can measure hundreds of kilometres across. As well as affecting Singapore’s air quality and visibility, the air pollution can spread to Malaysia, southern Thailand and the Philippines. This can have a major impact on the health of the people and plants of these countries, and of course those of Indonesia itself.
While considering this situation, I couldn’t help notice the presence of palm oil still in chocolate sold throughout Singapore, unlike certain other countries where it has been removed due to public concerns around the environmental impacts of a huge increase in palm oil plantations. Similarly the importation of palm kernels for use as a supplementary feed to dairy cows in New Zealand, needs a mention. Reflecting on this as well as the widespread use of palm oil in cheap vegetable oils and in many other food and non food consumer items found globally, there is clearly a need to address the underlying cause of such environmental pollution and factors responsible for poor human health, in a more integrative way. This burning of indigenous forests in Indonesia is related also to poverty as well as poor regulation by authorities there, but corporate greed, consumer usage and lack of awareness or concern for environmental and economic impacts, is contributory.
Ashwagandha (Withania somnifera) is a herb native to India and the Asian subcontinent, used as a tonic and treatment for a wide range of health conditions and perceived benefits. Known among herbalists as an ‘adaptogen’, its best known action is to help improve the body’s resilience to stress. Withania normalises blood levels of cortisol and other adrenal hormones during chronic stress, and exhibits a large number of actions suggesting an ability to insulate against adverse environmental stressors. This results in reduced anxiety, and a subtle but welcome retention of a sense of still being ‘in control’, during times of stress (2,3).
Science is also starting to suggest superior nutritional properties for organic crops. A ten year comparison of the influence of organic and conventional crop management practices on tomato flavonoid content, measured higher levels of the antioxidant lavonoids quercetin and kaempferol in organic tomatoes(2). Studies have also found enhanced organoleptic and taste qualities of organic versus non organic apples(3).

Most medicinal herbs are grown in developing countries, where programmes to control exposures to agrichemicals are either limited or non-existent. Many agrichemicals are toxic to handle, and pose significant risks, particularly in the event of accidental spills or inhalations. Children are particularly vulnerable to their harmful effects, with even very low levels of exposure during development potentially having adverse health effects. The World Health Organisation estimates that there are 3 million cases of pesticide poisoning each year and up to 220,000 deaths, primarily in developing countries.


